Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Thymidylate synthase, dihydropyrimidine dehydrogenase, ERCC1, and thymidine phosphorylase gene expression in primary and metastatic gastrointestinal adenocarcinoma tissue in patients treated on a phase I trial of oxaliplatin and capecitabine

Figure 3

Time to treatment failure as a function of ERCC1 gene expression. The median TTF was 162 days in those with ERCC1 expression < 3rd quartile (n = 46), compared to 85 days in those with expression > 3rd quartile (n = 16). The log-rank p-value is shown.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us